Convincingly disproving the notion that CSPG4 expression on normal tissues might pose a problem when targeting this molecule as a tumor antigen, is the inability of CSPG4-specific CAR T cells to identify and lyse normal cells in vitro [152]. Here, CSPG4 is linked to neoplasm.